Vaccine will be equally effective against new coronavirus strain: CSIR DG

Indian institutions have sequenced over 4,000 genomes of the coronavirus and submitted to the Global Initiative on Sharing All Influenza Data

Coronavirus, vaccine, covid, drugs, clinical trials
Press Trust of India New Delhi
3 min read Last Updated : Dec 21 2020 | 8:58 PM IST

The coronavirus vaccines will be equally effective against the new mutant of the virus and there is no reason to panic, Council for Scientific and Industrial Research Director General Shekhar Mande said on Monday.

He said the transmissibility of the new strain N501Y is a "bit higher" but this does not mean it is more lethal and more people are going to die due to it.

"It is likely that there will be differences between certain aspects like anti-bodies but it doesn't necessarily mean that vaccines will be ineffective. Vaccines will be equally effective despite the mutation. So there is no reason to panic," Mande told PTI.

Indian institutions have sequenced over 4,000 genomes of the coronavirus and submitted to the Global Initiative on Sharing All Influenza Data (GISAID).

The CSIR's Institute of Genomics and Integrative Biology (IGIB), Delhi and Centre for Cellular and Molecular Biology (CCMB), Hyderabad have alone done sequencing of over 2,200 genome sequences of coronavirus in India.

Mande said, "We have not found this (particular mutation) in Indian isolates yet." He said scientists in India and all over the world are watching this variant closely.

The mutation has been independently observed in the UK, Brazil and South Africa, he said.

"Scientists are looking at the mutations very closely. It is too early to draw any conclusions," Mande said.

He said the new variant can be diagnosed with the RT-PCR but it needs to be assessed if it can be equally effective for the Rapid Antigen tests. "But there is nothing to suggest it (RAT) does not work right now," he said.

Mande said there might be differences in the monoclonal (lab-made) antibodies which recognise the particular region in a virus which is not otherwise mutated.

"But in the mutated virus that monoclonal antibody may not effectively work against this changed variant," he added.

Several European countries -- France, Germany, the Netherlands, Belgium, Austria and Italy -- have banned flights from the UK with the British government warning that the potent new strain of the virus was "out of control" and imposing a stringent new stay-at-home lockdown from Sunday.

British Prime Minister Boris Johnson last week said a fast-moving new variant of the virus that is 70 per cent more transmissible than existing strains appeared to be driving the rapid spread of new infections in London and southern England in recent weeks. But he stressed "there's no evidence to suggest it is more lethal or causes more severe illness," or that vaccines will be less effective against it.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCSIR

First Published: Dec 21 2020 | 8:49 PM IST

Next Story